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Striking commonalities in the roles of complement and antimicrobial peptides have recently been
reported; their abilities to apply selection pressures on a bacterial population in the bloodstream (1),
to contribute to enhanced phagocytosis of opsonized bacteria (2), and to interactively determine
skin microbiome (3). Evolutionary roots for complement proteins and antimicrobial peptides are
ancient (4). Predating the avenue of somatic recombination, antimicrobial peptides and complement
have further emerged as modulators of cell activities that are part of the adaptive immune response.
Therefore, antimicrobial peptides and complement were logical contenders for a focused analysis
to distil from a wide complexity a range of overlapping and distinct activities that could serve to
maximize local and systemic inflammatory responses.
The task was ambitious. Aiming to draw together experts and junior scientists in two distinct
areas of inflammatory responses, an e-book series was produced which in its entirety challenges
oligofactorial analyses in health and disease and points to a gain in embracing more fully the
interconnection of inflammatory reactions and their components using, as examples, complement
and antimicrobial peptides.
Functional analytical approaches may be derived from genomic analyses using cross species
comparisons for antimicrobial peptides and is demonstrated in Machado and Ottolini’s article
(5). Significant copy number variations for defensin genes in and between populations make
these exciting modulators of inflammation, mucosal immunity, and infection responses. In the
complement system, gene duplication leading to C4A and C4B and functional polymorphisms in
the MBL gene (in humans) provide variability in the fluid phase of complement activation.
In two parts, Roumenina’s team provide a delicately researched state-of-the-art evaluation of
complement activation and its regulation as well as a summary of current understanding of the
mutlifaceted roles of complement anaphylatoxins in inflammation (6, 7).
Bevington’s group put forward a case in support of further avenues of research to identify pH
sensing molecules and understand pH-dependent contact and complement system activation and
their interactions (8). The activity of antimicrobial peptides is also influenced by pH conditions (9).
It appears therefore that more rigorous measurements of pH in in vivomodels may help to discern
a level of regulation that is currently still underappreciated.
Day and Clark’s group remind that sialic acids or glycosaminoglycan structures on the cell surface
or in the extracellular compartment provide interfaces, which can determine propagation or inhibi-
tion of complement activation and be the basis for tissue-specific susceptibilities to targeting binding
of complement proteins (10). Interestingly, inDrosophila, engagement of the sulfated polysaccharide
chains of heparin sulfate proteoglycans leads to expression of antimicrobial peptides (11).
Stadnyk’s group presents a program of work to test hypotheses or inferred models of inter-
action, which are relevant in understanding pathomechanisms of colitis, but also contribute to
our understanding of mucosal tolerance (12). Much has yet to be gained from studying the
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luminal role of antimicrobial peptides vs. the mucosal role of
complement to maintain the mucosal barrier (13).
In the periodontal pocket, Porphyromonas gingivalis, its recip-
rocal interaction with complement and antimicrobial peptides
during periodontitis is associated with altered local micro-
biota, bone loss, and evasion to atherosclerotic plaque (14).
Chemokines, for which direct antimicrobial activities have
been shown, are the focus in Sahingur and Yeudall’s trea-
tise on molecular determinants in the development and pro-
gression of oral cavity cancers. Produced in response to a
polymicrobial insult, locally produced chemokines are rele-
vant to epithelial dysplasia and osteoclast activity and, fur-
thermore, shape the tumor microenvironment (15). Al-Rayahi
and Sanyi juxtapose complex activities of antimicrobial pep-
tides and complement components in a wide range of can-
cers and remind us of early tumoricidal work using bacterial
extracts (16).
Rocha-Ferreira and Hristova discuss for the neonatal brain the
role of complement and antimicrobial peptides in the dynam-
ics and extent of inflammation and their potential as targetable
mediators of hypoxia-induced brain damage (17).
A cautionary tale is told by Schuerholz et al. and Thompson
et al., who deal with antimicrobial peptides and complement,
respectively, in human sepsis (18, 19). Interactions of host to
pathogen are multimodal and immune markers alter over the
duration of disease. It seems reasonable to propose that parallel
measurement of humorally accessible complement and antimicro-
bial peptides, players of the innate immunity bridging the adaptive
immunity, will yield greater understanding of the dynamic host
response during sepsis.
Finally, Zimmer et al. systematically present activity signa-
tures of complement and antimicrobial peptides in homeosta-
sis and disease (20) and point to a need to distinguish other
activities, which relate to routine design of recombinant protein
expression (21).
In their entirety, the contributions, by providing succinct
and critical summaries, primary data and viewpoints, achieve to
deepen insight in and understanding of complexmatters involving
and surrounding antimicrobial peptides and complement. The
mind may become more prepared to consider a multipronged
approach to health and disease, impacting on both, experimental
and therapeutic designs.
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